CA2203791A1 - Analogues synthetiques d'acides gras polyinsatures - Google Patents
Analogues synthetiques d'acides gras polyinsaturesInfo
- Publication number
- CA2203791A1 CA2203791A1 CA 2203791 CA2203791A CA2203791A1 CA 2203791 A1 CA2203791 A1 CA 2203791A1 CA 2203791 CA2203791 CA 2203791 CA 2203791 A CA2203791 A CA 2203791A CA 2203791 A1 CA2203791 A1 CA 2203791A1
- Authority
- CA
- Canada
- Prior art keywords
- acid
- otbu
- glycine
- tfa
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des composés d'acides gras polyinsaturés présentant une activité antipaludéenne et/ou neutrophilo-stimulante, ou une activité anti-inflammatoire. Ces acides gras polyinsaturés, qui contiennent une chaîne de 16 à 26 atomes de carbones et 3 à 6 bandes doubles, sont couplés en covalence au groupe carboxylique d'un acide aminé. Dans une réalisation préférée, l'acide gras contient de 18 à 22 atomes de carbones et l'acide aminé est l'acide aminoacétique ou l'acide aspartique. Les composés préférés sont acide .gamma.-linoléïque - acide aminoacétique, acide .alpha.-linoléïque - acide aminoacétique, acide arachidonique - acide aminoacétique, acide docosahexaénoïque - acide aminoacétique, acide eicosapentaénoïque - acide aminoacétique, acide .gamma.-linoléïque - acide aspartique, acide .alpha.-linoléïque - acide aspartique, acide arachidonique - acide aspartique, acide eicosapentaénoïque - acide aspartique et acide docosahexaénoïque - acide aspartique.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM9065A AUPM906594A0 (en) | 1994-10-26 | 1994-10-26 | Synthetic polyunsaturated fatty acid analogues |
AUPM9065 | 1994-10-26 | ||
PCT/AU1995/000717 WO1996013507A1 (fr) | 1994-10-26 | 1995-10-25 | Analogues synthetiques d'acides gras polyinsatures |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2203791A1 true CA2203791A1 (fr) | 1996-05-09 |
Family
ID=29402800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2203791 Abandoned CA2203791A1 (fr) | 1994-10-26 | 1995-10-25 | Analogues synthetiques d'acides gras polyinsatures |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2203791A1 (fr) |
-
1995
- 1995-10-25 CA CA 2203791 patent/CA2203791A1/fr not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0804411B1 (fr) | Analogues synthetiques d'acides gras polyinsatures | |
Herberman et al. | Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes | |
ES2332616T3 (es) | Peptidos de quimiocinas, variantes, derivados y analogos, su utilizacion en metodos para inhibir o aumentar una respuesta inflamatoria. | |
Grau et al. | Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation. | |
Howard et al. | Interleukin 10 protects mice from lethal endotoxemia. | |
Sticherling et al. | Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin | |
US6368788B1 (en) | Method of treating complications in immunodepressed states resulting from HIV infection | |
JPH10507179A (ja) | 修飾ポリ不飽和脂肪酸 | |
Yamaoka et al. | Leukotriene B4 induces interleukin 5 generation from human T lymphocytes | |
Waters et al. | Killing of Plasmodium falciparum by eosinophil secretory products | |
CN1047035A (zh) | 生物应答修饰因子的新颖抗体传递系统 | |
Spry | Synthesis and secretion of eosinophil granule substances | |
CA2104958A1 (fr) | Utilisation de molecules ciblees sur les recepteurs de la surface cellulaire pour le traitement des maladies virales | |
EA014070B1 (ru) | Применение растительной композиции для лечения воспалительных нарушений | |
JPH07502978A (ja) | Tnf及び/またはlps毒性を抑制するペプチド | |
Silberstein et al. | Hemopoietins for eosinophils: glycoprotein hormones that regulate the development of inflammation in eosinophilia-associated disease | |
JP4708511B2 (ja) | 胆汁由来免疫調節組成物 | |
JPH04504111A (ja) | ヒトマクロファージ遊走阻止因子 | |
AU686898B2 (en) | Synthetic polyunsaturated fatty acid analogues | |
Talcott et al. | The effect of lead and polychlorinated biphenyl exposure on rat natural killer cell cytotoxicity | |
US5807830A (en) | Method for treatment of purulent inflammatory diseases | |
CA2203791A1 (fr) | Analogues synthetiques d'acides gras polyinsatures | |
JP4160532B2 (ja) | 免疫を増強するための医薬組成物、およびポリア抽出物 | |
Kołodziej-Sobocińska et al. | Trichinella spiralis: macrophage activity and antibody response in chronic murine infection | |
CN1087278A (zh) | 溶菌酵素二聚体的新用途及其含有溶菌酵素二聚体的制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |